NEW YORK (GenomeWeb) – Veracyte has appointed Cepheid Chairman and CEO John Bishop to its board of directors. He also will join the board's compensation committee. Bishop replaces Samuel Colella, who resigned from the board, effective Nov. 30.

Bishop has a long track record in the molecular diagnostics industry, previously serving as president and CEO of Vysis, which was acquired by Abbott Laboratories; chairman and CEO of MicroProbe; and president and COO of Gen-Probe, among other executive positions.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.